Abstract
To the Editor: In their very interesting paper, Rehman et al1 demonstrate that the vast majority of peripheral blood–derived acLDL+ Ulex-lectin+ cells in culture—often referred to as endothelial progenitor cells (EPC)—express monocyte/macrophage markers, indicating that they originate mainly from the monocyte/macrophage lineage. They suggest that only a small population of true stem cells/progenitor cells and endothelial cells exists that may originate directly from the hemangioblast or from hematopoietic stem cells. Our recent observations support their findings that the majority of EPC are derived from the monocyte/macrophage–containing CD34− mononuclear cell population. Nevertheless, we could also identify and quantify a minor proportion of EPC that has its origin in the hematopoietic stem …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.